John Maher

10.7k total citations · 2 hit papers
188 papers, 7.8k citations indexed

About

John Maher is a scholar working on Oncology, Immunology and Biomedical Engineering. According to data from OpenAlex, John Maher has authored 188 papers receiving a total of 7.8k indexed citations (citations by other indexed papers that have themselves been cited), including 96 papers in Oncology, 66 papers in Immunology and 29 papers in Biomedical Engineering. Recurrent topics in John Maher's work include CAR-T cell therapy research (89 papers), Immunotherapy and Immune Responses (32 papers) and Immune Cell Function and Interaction (30 papers). John Maher is often cited by papers focused on CAR-T cell therapy research (89 papers), Immunotherapy and Immune Responses (32 papers) and Immune Cell Function and Interaction (30 papers). John Maher collaborates with scholars based in United Kingdom, United States and Ireland. John Maher's co-authors include David M. Davies, Michel Sadelain, Gertrude Gunset, Isabelle Rivière, Renier J. Brentjens, Lynsey M. Whilding, May CI van Schalkwyk, Scott Wilkie, Ana C. Parente‐Pereira and Daniela Achkova and has published in prestigious journals such as New England Journal of Medicine, Proceedings of the National Academy of Sciences and The Lancet.

In The Last Decade

John Maher

181 papers receiving 7.5k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Human T-lymphocyte cytotoxicity and proliferation directed by a single chimeric TCRζ /CD28 receptor

2002 796 citations John Maher et al. profile →
T cell response to SARS-CoV-2 infection in humans: A systematic review

2021 255 citations Madhumita Shrotri, May CI van Schalkwyk et al. profile →

Peers

Countries citing papers authored by John Maher

Since Specialization

Citations

This map shows the geographic impact of John Maher's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by John Maher with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites John Maher more than expected).

Fields of papers citing papers by John Maher

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by John Maher. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by John Maher. The network helps show where John Maher may publish in the future.

Co-authorship network of co-authors of John Maher

This figure shows the co-authorship network connecting the top 25 collaborators of John Maher. A scholar is included among the top collaborators of John Maher based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with John Maher. John Maher is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Solid tumor immunotherapy using NKG2D-based adaptor CAR T cells 2024 ·Cell Reports Medicine ·(unknown), Daniel Larcombe-Young, (unknown), Fahima Kausar, Caroline Hull, (unknown), Ge Tan, Richard Beatson, (unknown), Roberta Mazza, (unknown), Chelsea Taylor, Andrea Billè, Katelyn M. Spillane, Domenico Cozzetto, Alessandra Vigilante, Anna Schurich, David M. Davies, John Maher	12
2	Granzyme B-activated IL18 potentiates αβ and γδ CAR T cell immunotherapy in a tumor-dependent manner 2024 ·Molecular Therapy ·Caroline Hull, Daniel Larcombe-Young, Roberta Mazza, (unknown), David M. Davies, Anna Schurich, John Maher	18
3	CAR-T cell technologies that interact with the tumour microenvironment in solid tumours 2024 ·Expert Review of Clinical Immunology ·Chelsea Taylor, (unknown), John Maher	4
4	CAR-Based Immunotherapy of Solid Tumours—A Survey of the Emerging Targets 2023 ·Cancers ·John Maher, David M. Davies	17
5	Harnessing Nanomedicine to Potentiate the Chemo-Immunotherapeutic Effects of Doxorubicin and Alendronate Co-Encapsulated in Pegylated Liposomes 2023 ·Pharmaceutics ·Alberto Gabizón, Hilary Shmeeda, Benjamin Draper, Ana C. Parente‐Pereira, John Maher, (unknown), Rafael T. M. de Rosales, Ninh M. La‐Beck	3
6	Solid tumours: Building bridges to CAR‐T success 2023 ·SHILAP Revista de lepidopterología ·John Maher	2
7	Chimeric Antigen Receptor (CAR) T-Cell Therapy for Patients with Lung Cancer: Current Perspectives 2023 ·OncoTargets and Therapy ·John Maher	7
8	CAR T-Cell Targeting of Macrophage Colony-Stimulating Factor Receptor 2022 ·Cells ·Daniela Achkova, Richard Beatson, John Maher	8
9	Generation and application of TGFβ-educated human Vγ9Vδ2 T cells 2022 ·STAR Protocols ·Ana C. Parente‐Pereira, Richard Beatson, David M. Davies, Caroline Hull, Lynsey M. Whilding, Joanna C. Porter, John Maher	3
10	Priming Death Receptor Mediated Apoptosis with Arginine Starvation Sensitises Arginine Auxotrophic B-ALL to CAR-T 2021 ·Blood ·(unknown), Leena Halim, Farideh Miraki‐Moud, David Taussig, John S. Bomalaski, John Maher, John G. Gribben, Peter W. Szlosarek, (unknown)	0
11	Cellular immune response to SARS-CoV-2 infection in humans: a systematic review 2020 ·medRxiv ·Madhumita Shrotri, May CI van Schalkwyk, Nathan Post, Danielle Eddy, Catherine Huntley, David Leeman, Samuel Rigby, Sarah Williams, William Bermingham, Paul Kellam, John Maher, Adrian Shields, Gayatri Amirthalingam, Sharon J. Peacock, Sharif Ismail	4
12	Editor's Pick: Tumour-Associated Hypoxia: Can We Give Chimeric Antigen Receptor T Cells More Breathing Space? 2020 ·SHILAP Revista de lepidopterología ·(unknown), Paris Kosti, Anna Schurich, James N. Arnold, John Maher	1
13	Overcoming Immunological Resistance Enhances the Efficacy of a Novel Anti-tMUC1-CAR T Cell Treatment against Pancreatic Ductal Adenocarcinoma 2019 ·Cells ·Mahboubeh Yazdanifar, Ru Zhou, Priyanka Grover, Chandra Williams, Mukulika Bose, Laura J. Moore, (unknown), John Maher, Didier Dréau, Pinku Mukherjee	49
14	Perspectives on Chimeric Antigen Receptor T-Cell Immunotherapy for Solid Tumors 2018 ·Frontiers in Immunology ·Paris Kosti, John Maher, James N. Arnold	93
15	CAR T-cell immunotherapy of MET-expressing malignant mesothelioma 2017 ·OncoImmunology ·(unknown), Roseanna M. Petrovic, Daniela Achkova, Tomasz Zabinski, David M. Davies, Astero Klampatsa, Ana C. Parente‐Pereira, Lynsey M. Whilding, (unknown), Natalie Woodman, Michael Sheaff, Jennifer R. Cochran, James Spicer, John Maher	52
16	Adoptive T-Cell Therapy for Cancer in the United Kingdom: A Review of Activity for the British Society of Gene and Cell Therapy Annual Meeting 2015 2015 ·Human Gene Therapy ·David E. Gilham, John Anderson, John S. Bridgeman, Robert E. Hawkins, Mark A. Exley, Hans J. Stauss, John Maher, Martin Pulé, Andrew K. Sewell, Gavin Bendle, Steven Lee, Waseem Qasim, Adrian J. Thrasher, Emma Morris	15
17	Design of a Phase I Clinical Trial to Evaluate Intratumoral Delivery of ErbB-Targeted Chimeric Antigen Receptor T-Cells in Locally Advanced or Recurrent Head and Neck Cancer 2013 ·PubMed ·May CI van Schalkwyk, Sophie Papa, Jean‐Pierre Jeannon, Teresa Guerrero Urbano, James Spicer, John Maher	105
18	Flexible Targeting of ErbB Dimers That Drive Tumorigenesis by Using Genetically Engineered T Cells 2012 ·Molecular Medicine ·David M. Davies, Julie Foster, Sjoukje J. C. van der Stegen, Ana C. Parente‐Pereira, Laura Chiapero-Stanke, (unknown), S. Burbridge, (unknown), Zhe Liu, Leticia Bosshard‐Carter, May CI van Schalkwyk, Carol Box, Suzanne A. Eccles, Stephen J. Mather, Scott Wilkie, John Maher	95
19	Skin anergy and tuberculosis 1992 ·Respiratory Medicine ·John Maher, Patricia J. Kelly, Philippa Hughes, Luke Clancy	13
20	Renal function following cortical necrosis in childhood 1971 ·The Journal of Pediatrics ·(unknown), Addison A. Taylor, Karl D. Nolph, James A. Esterly, John Maher	9

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact